Smith & Nephew, Inc.: Joint Diseases trials

The registry lists 12 Joint Diseases studies with Smith & Nephew, Inc. as lead sponsor. 0 are open to participants now and 5 have results posted.

No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study to Evaluate the Safety and Efficacy of OR3O™ Dual Mobility System vs. Conventional Single Bearing Design Total Hip SystemTerminatedNCT04941729Not applicableResults posted
• Study to Evaluate the Safety and Effectiveness of REAL INTELLIGENCE™ CORI™ in Unicondylar Knee Arthroplasty (UKA) ProceduresTerminatedNCT04797897Not applicableResults posted
• EU Safety and Efficacy Study Regarding the R3 Acetabular Hip SystemCompletedNCT04399928Results posted
• Post-Approval Study of the R3 Biolox Delta Ceramic Acetabular System - EuropeCompletedNCT03566082Results posted
• R3 Delta Ceramic Acetabular System PAS U.S.CompletedNCT03056534Results posted
• A Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip SystemActive, not recruitingNCT06564636
• A Comparison of Patients Receiving a Unicompartmental Knee Replacement With Robotic Assistance or With Conventional InstrumentationWithdrawnNCT04992078Not applicable
• A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional InstrumentationWithdrawnNCT04976972Not applicable
• Journey™ UNI Post Market Clinical Follow-UpActive, not recruitingNCT03442231
• Clinical Outcome Following Total Hip Arthroplasty With the SMF StemTerminatedNCT02471703
• Post Market Clinical Follow Up of LEGION™ Primary TKS With VERILAST™Active, not recruitingNCT02380092
• Journey II BCS EU Observational TrialActive, not recruitingNCT02211794